A British startup has embedded 156 sensor plates beneath 60 metres of track at Cardiff’s National Indoor Athletics Centre, marking the opening shot of an 18-month pilot programme. The technology, built by
In one of the most dramatic episodes in American legal history, a sitting chief justice gave up his seat on the bench to settle a political score with a pistol. In 1859,
More
Lloyds Banking Group (LSE: LLOY) has emerged as one of the FTSE 100’s standout performers over the past 12 months, with its share price climbing to levels not seen since 2008. In
More
The August jobs report, due out Friday, is expected to confirm what has been one of the weakest summers for employment growth in recent years. Economists polled by Dow Jones project nonfarm
More
Reform UK’s Treasury spokesman Robert Jenrick has declined to rule out a tax on profitable banks, despite the party hosting City industry representatives at its first-ever Business Day conference event. Jenrick told
More
Replimune (REPL) secured a landmark accelerated approval for its cancer therapy Tudriqev last month, following a pivotal intervention from senior FDA leadership. Two votes of confidence from officials at the FDA’s Office
More
The U.S. Environmental Protection Agency granted Alaska final authorization to administer its own hazardous waste management program on July 29, 2026. Alaska is now the 49th state authorized to administer most aspects
More
London’s blue-chip index closed firmly higher on Thursday, with the FTSE 100 gaining 0.70% as encouraging economic data buoyed investor sentiment across the market. The rally was driven by the latest purchasing
More
Federal Reserve Governor Christopher Waller said Thursday he is leaning toward keeping interest rates steady at the central bank’s September meeting. Waller’s position is contingent on no major surprises emerging from upcoming
More
On August 26, Nepal was hit by a major natural disaster after a glacier collapsed above the Trishuli River. The resulting floods destroyed homes, roads and bridges across affected areas, leaving communities
More
Amgen (AMGN) has unveiled compelling new data showing its cholesterol-lowering drug Repatha significantly reduces the risk of death in high-risk cardiovascular patients. The findings, announced on 31 August 2026, come from a
More